Skip to main content
. 2022 Dec 30;21(6):2290–2297. doi: 10.1111/ajt.16634

TABLE 1.

Number and percentage of skilled nursing facility residents and staff members with a positive confirmed SARS-CoV-2 test result, by demographic and clinical characteristics and vaccination status — Chicago, Illinois, December 2020–March 2021

Characteristic Vaccination status of residents and staff members with SARS-CoV-2 infections, no. (column %)
Total (n = 627) Unvaccinateda (n = 447) Partially vaccinateda (n = 145) Vaccinated but not immunea (n = 13) Fully vaccinated with breakthrough infectiona (n = 22)
Median age (IQR) 60.0 (43.0–73.0) 57.0 (39.0–71.0) 65.0 (50.0–79.0) 66.0 (58.0–79.0) 61.5 (41.0–73.0)
Sex
Female 376 (60.0) 265 (59.3) 89 (61.4) 7 (53.9) 15 (68.2)
Male 237 (37.8) 168 (37.6) 56 (38.6) 6 (46.2) 7 (31.8)
Unknown 14 (2.2) 14 (3.1) 0 (–) 0 (–) 0 (–)
Race/ethnicity
Hispanic/Latino 58 (9.3) 37 (8.3) 16 (11.0) 1 (7.7) 4 (18.2)
Asian, non-Hispanic 24 (3.8) 11 (2.5) 9 (6.2) 1 (7.7) 3 (13.6)
Black, non-Hispanic 252 (40.2) 193 (43.2) 44 (30.3) 7 (53.9) 8 (36.4)
White, non-Hispanic 144 (23.0) 79 (17.7) 55 (37.9) 3 (23.1) 7 (31.8)
Other,b non-Hispanic 16 (2.6) 12 (2.7) 4 (2.8) 0 (–) 0 (–)
Unknown 133 (21.2) 115 (25.7) 17 (11.7) 1 (7.7) 0 (–)
Role
Resident 353 (56.3) 235 (52.6) 97 (66.9) 9 (69.2) 12 (54.6)
Staff member 274 (43.7) 212 (47.4) 48 (33.1) 4 (30.8) 10 (45.5)
Symptomsc
Yes 92 (14.7) 62 (13.9) 21 (14.5) 1 (7.7) 8 (36.4)
No 34 (5.4) 15 (3.4) 5 (3.5) 0 (–) 14 (63.6)
Unknown 501 (79.9) 370 (82.8) 119 (82.1) 12 (92.3) 0 (–)
Hospitalizations
Yes 123 (19.6) 90 (20.1) 27 (18.6) 2 (15.4) 4 (18.2)d
No 504 (80.4) 357 (79.9) 118 (81.4) 11 (84.6) 18 (81.8)
Deaths
Yes 21 (3.4) 14 (3.1) 6 (4.1) 0 (–) 1 (4.6)
No 606 (96.7) 433 (96.9) 139 (95.9) 13 (100.0) 21 (95.5)
Previous positive SARS-CoV-2 result
Yes 41 (6.5) 22 (4.9) 9 (6.2) 4 (30.8) 6 (27.3)
No 586 (93.5) 425 (95.1) 136 (93.8) 9 (69.2) 16 (72.7)

Abbreviations: I-NEDSS, Illinois’ National Electronic Disease Surveillance System; IQR, interquartile range.

a

Unvaccinated: received no COVID-19 vaccine doses; partially vaccinated: received one dose; vaccinated but not immune: received two doses but <14 days had elapsed since receipt of second dose; and fully vaccinated with breakthrough infection: received two doses and then received a positive SARS-CoV-2 test result ≥14 days after receipt of the second dose.

b

Persons with the following races listed in I-NEDSS as American Indian or Alaska Native, Native Hawaiian or other Pacific Islander, other, or multiracial were categorized as non-Hispanic other.

c

Data on symptoms were extracted from I-NEDSS for unvaccinated, partially vaccinated, and vaccinated but not immune persons. Most COVID-19 case reports are entered into I-NEDSS through electronic laboratory reporting and provide minimal information (e.g., name, date of birth, and laboratory test and results) needed to meet reporting requirements. Data on symptoms in persons with breakthrough infections were supplemented with details from case investigations, which were not completed for nonbreakthrough cases. Symptom status for many persons with nonbreakthrough infection cases is unknown.

d

Two residents were hospitalized for COVID-19–related reasons. Two additional residents were hospitalized for non-COVID-19–related reasons.